Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in “real-world” clinical practice. A propensity-matched analysis of 76,940 patients - Li, X S; Deitelzweig, S; Keshishian, A (Thromb Haemost, 2017)
, et al.